---
title: "12 Health Care Stocks Moving In Tuesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294063861.md"
description: "In Tuesday's pre-market session, several healthcare stocks saw significant movement. Gossamer Bio surged 47.2% to $0.29, while Prelude Therapeutics rose 20.3%. Other gainers included ProMIS Neurosciences, Aldeyra Therapeutics, Altimmune, and IQVIA Holdings, with the latter rising on Q2 earnings news. Conversely, Replimune Group dropped 24.7%, followed by declines in Nexalin Technology, BiomX, Outlook Therapeutics, Autonomix Medical, and China SXT Pharmaceuticals."
datetime: "2026-07-28T12:05:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294063861.md)
  - [en](https://longbridge.com/en/news/294063861.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294063861.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

### Gainers

-   **Gossamer Bio** (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $97.4 million.
-   **Prelude Therapeutics** (NASDAQ:PRLD) shares moved upwards by 20.3% to $4.68. The market value of their outstanding shares is at $309.8 million.
-   **ProMIS Neurosciences** (NASDAQ:PMN) stock increased by 16.46% to $13.65. The company's market cap stands at $105.1 million.
-   **Aldeyra Therapeutics** (NASDAQ:ALDX) shares moved upwards by 11.04% to $1.76. The company's market cap stands at $95.6 million.
-   **Altimmune** (NASDAQ:ALT) stock rose 8.8% to $3.22. The market value of their outstanding shares is at $575.6 million.
-   **IQVIA Holdings** (NYSE:IQV) shares rose 8.76% to $231.9. The company's market cap stands at $35.5 billion. As per the news, the Q2 earnings report came out today.

### Losers

-   **Replimune Group** (NASDAQ:REPL) shares fell 24.7% to $6.5 during Tuesday's pre-market session. The company's market cap stands at $724.4 million.
-   **Nexalin Technology** (NASDAQ:NXL) stock decreased by 16.29% to $0.37. The market value of their outstanding shares is at $9.7 million.
-   **BiomX** (AMEX:PHGE) shares decreased by 12.92% to $0.17. The market value of their outstanding shares is at $2.1 million.
-   **Outlook Therapeutics** (NASDAQ:OTLK) shares decreased by 11.92% to $0.94. The company's market cap stands at $158.2 million.
-   **Autonomix Medical** (NASDAQ:AMIX) shares fell 11.83% to $2.46. The company's market cap stands at $1.5 million.
-   **China SXT Pharmaceuticals** (NASDAQ:SXTC) shares decreased by 11.61% to $0.06. The company's market cap stands at $2.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [ALT.US](https://longbridge.com/en/quote/ALT.US.md)
- [OTLK.US](https://longbridge.com/en/quote/OTLK.US.md)
- [REPL.US](https://longbridge.com/en/quote/REPL.US.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [PHGE.US](https://longbridge.com/en/quote/PHGE.US.md)
- [ALDX.US](https://longbridge.com/en/quote/ALDX.US.md)
- [PRLD.US](https://longbridge.com/en/quote/PRLD.US.md)
- [GOSS.US](https://longbridge.com/en/quote/GOSS.US.md)
- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)
- [IQV.US](https://longbridge.com/en/quote/IQV.US.md)
- [NXL.US](https://longbridge.com/en/quote/NXL.US.md)
- [PMN.US](https://longbridge.com/en/quote/PMN.US.md)
- [NXLIW.US](https://longbridge.com/en/quote/NXLIW.US.md)

## Related News & Research

- [Research Analysts Issue Forecasts for ALDX Q3 Earnings](https://longbridge.com/en/news/296353895.md)
- [17:00 ETReplimune Group, Inc. (REPL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/296955124.md)
- [Evolve Private Wealth LLC Invests $886,000 in IQVIA Holdings Inc. $IQV](https://longbridge.com/en/news/296754498.md)
- [Mitsubishi UFJ Asset Management Co. Ltd. Takes $78.51 Million Position in IQVIA Holdings Inc. $IQV](https://longbridge.com/en/news/296333827.md)
- [Nexalin Technology Announces $0.75M Direct Offering and $15M Equity Purchase Facility With Alumni Capital](https://longbridge.com/en/news/296538958.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**